Routine surveillance after carotid endarterectomy: does it affect clinical management?

Although routine noninvasive surveillance is recommended after carotid endarterectomy (CEA), there are little data to show that identification and eradication of recurrent carotid artery stenosis are necessary to avoid the risk of subsequent neurologic complications.

We reviewed our experience over a 16-year period in 380 consecutive patients undergoing 409 CEAs who underwent serial postoperative ultrasonic scanning at 6 weeks, 6 months, and 1 year after CEA and then yearly thereafter.

Recurrent stenoses (> or = 50% diameter reduction) were detected in 44 arteries (10.8%) during follow-up from 1 to 177 months (mean 42.0 months). Most (70.5%) occurred within 2 years of CEA. Cumulative recurrence rates were 5.8%, 9.9%, 13.9%, and 23.4% at 1, 3, 5, and 10 years, respectively. Recurrent stenoses were more frequent in female (p = 0.02) and younger patients (p = 0.01) and less frequent in those having a vein patch repair (p = 0.02). Most recurrences (84%) were in the 50% to 79% stenosis range. In four patients 80% to 99% stenoses developed and in three patients total occlusions developed, for a severe recurrence rate of 2.1%. Only 10 (22.7%) of the recurrent stenoses were initially symptomatic, and only one (2.9%) of the asymptomatic restenoses later became symptomatic. One patient with recurrent stenosis suffered a stroke (0.3%). Cumulative 5-year ipsilateral stroke-free rates in patients with recurrent stenosis (94.4%) were practically identical (p = 0.76) to those in patients without recurrent stenosis (94.2%). Life-table ipsilateral stroke-free survival rates at 5 years were 94.2% in patients with recurrent stenosis and 78.4% in patients without recurrent stenosis (p = 0.16). Four (9%) recurrent stenoses and 12 lesions (27%) in the contralateral artery progressed. Only seven patients (1.7%) underwent repeat operation for ipsilateral disease, four for symptoms and three for recurrent stenosis.

Recurrent carotid artery stenosis occurs early after CEA, is typically benign, and remains stable over a prolonged follow-up period. Our results question the importance of routine noninvasive surveillance after CEA and suggest that a more conservative approach would be equally beneficial in terms of clinical relevance and cost-effectiveness.